Barton Shane
Transaction: 06/30/2026
SELL
Change
-20,216
Price
$25.19
Filing
07/01/2026
Type
SELL
BioAge Labs Inc.
BIOA • Biotechnology
$9.59
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$430.00M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 14.24Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$9.59
Change0.00%
Shares Out44.84M
Market Cap$430.00M
Enterprise Value$111.26M
52W Range4.25 - 25.95
Beta0.93
P/E-4.55
P/S41.53
P/B1.15
P/FCF-3.83
EV/Sales10.74
Price$9.59
Change0.00%
Shares Out44.84M
Market Cap$430.00M
Enterprise Value$111.26M
52W Range4.25 - 25.95
Beta0.93
P/E-4.55
P/S41.53
P/B1.15
P/FCF-3.83
EV/Sales10.74
EV/EBITDA-1.11
EV/FCF-0.99
Earnings Yield-21.97%
FCF Yield-26.08%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-10.31%
Profit Margin-8.96%
Debt/Eq0.02
Current Ratio14.24
Quick Ratio14.24
Target$34.00
Target Upside254.54%
Target Median$32.50
Target Range21.00 - 50.00
Volume821.49K
Avg Volume760.14K
EPS Surprise0.12
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
54/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 14.24Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$21.00
Mean
$34.00
Median
$32.50
High
$50.00
Insider Transactions
Recent executive and insider activity
Barton Shane
Transaction: 06/30/2026
SELL
Change
-4,290
Price
$10.85
Filing
07/01/2026
Type
SELL
Barton Shane
Transaction: 06/29/2026
SELL
Change
-42,350
Price
$25.21
Filing
07/01/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Barton Shane | SELL | -20,216 | $25.19 | 06/30/2026 | 07/01/2026 |
| Barton Shane | SELL | -4,290 | $10.85 | 06/30/2026 | 07/01/2026 |
| Barton Shane | SELL | -42,350 | $25.21 | 06/29/2026 | 07/01/2026 |
| Barton Shane | SELL | -9,301 | $10.85 | 06/29/2026 | 07/01/2026 |
| GARNIER JEAN PIERRE | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| Davidson Michael H. | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| ENRIGHT PATRICK G | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| HEALY JAMES | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| Hemrajani Rekha | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| Pande Vijay Satyanand | BUY | +22,000 | $15.48 | 06/10/2026 | 06/12/2026 |
| GOLDSTEIN DOV A MD | BUY | +3,542 | $4.38 | 04/23/2026 | 04/24/2026 |
| GOLDSTEIN DOV A MD | SELL | -3,542 | $4.38 | 04/23/2026 | 04/24/2026 |
| RUBIN PAUL D | SELL | -3,383 | $6.57 | 04/01/2026 | 04/03/2026 |
| RUBIN PAUL D | SELL | -8,820 | $17.81 | 04/01/2026 | 04/03/2026 |
| RUBIN PAUL D | SELL | -2,000 | $6.57 | 03/02/2026 | 03/03/2026 |
| RUBIN PAUL D | SELL | -7,433 | $20.30 | 03/02/2026 | 03/03/2026 |
| GOLDSTEIN DOV A MD | BUY | +3,542 | $4.38 | 03/01/2026 | 03/03/2026 |
| GOLDSTEIN DOV A MD | SELL | -3,542 | $4.38 | 03/01/2026 | 03/03/2026 |
| Barton Shane | BUY | +45,000 | $19.63 | 02/17/2026 | 02/19/2026 |
| Fortney Kristen | BUY | +330,000 | $19.63 | 02/17/2026 | 02/19/2026 |